Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians

Annals of Pharmacotherapy - Tập 38 Số 9 - Trang 1449-1459 - 2004
Rupali Jain1, Larry H. Danziger2
1Rupali Jain PharmD, Infectious Diseases Fellow, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL
2Larry H Danziger PharmD, Professor of Pharmacy, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago

Tóm tắt

OBJECTIVE: To review and evaluate clinically relevant epidemiology, microbiology, and clinical studies regarding the treatment of multidrug-resistant Acinetobacter infections. DATA SOURCES: Pertinent literature was identified by a MEDLINE search (1966-September 2003) and through secondary bibliographies of pertinent articles. STUDY SELECTION AND DATA EXTRACTION: All English-language articles identified from data sources were evaluated for clinical relevance. DATA SYNTHESIS: Acinetobacter baumannii has emerged as a worldwide problem as a nosocomial pathogen in hospitalized patients. Acinetobacter spp. can cause a multitude of infections including pneumonia, bacteremia, meningitis, urinary tract infections, and skin and soft tissue infections, and the mortality associated with these infections is high. Isolates resistant to almost all commercially available antimicrobials have been identified, thus limiting treatment options. The development of new agents and reappraisal of older compounds (ie, polymyxins, ampicillin/sulbactam) are necessary as we consider the optimal treatment of these multidrug-resistant organisms. CONCLUSIONS: There is no simple answer to the treatment of Acinetobacter infections. Eradication of Acinetobacter spp. requires adherence to good infection control practices and prudent antibiotic use, as well as effective antimicrobial therapy. Alternative therapies such as colistin, ampicillin/sulbactam, and tetracycline are potential options, but prospective, randomized, controlled trials are still lacking.

Từ khóa


Tài liệu tham khảo

10.1097/00003246-199905000-00020

10.1086/313710

10.1086/320183

Allen DM, 2000, Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5, 2339

10.1093/oxfordjournals.aje.a115714

10.1097/00005792-199511000-00004

10.1093/clinids/22.6.1026

10.1086/322584

10.1093/clinids/23.3.538

10.1128/CMR.9.2.148

10.1016/S0140-6736(94)90694-7

10.1086/502091

10.1086/502046

10.1016/S0305-4179(02)00012-8

Gerner-Smidt P, 1994, APMIS Suppl, 47, 1

10.1099/00207713-36-2-228

10.1016/0196-6553(85)90059-8

10.1016/0195-6701(90)90128-B

10.1017/S0022172400070509

10.1128/JCM.25.3.488-490.1987

10.1093/infdis/151.2.252

10.1016/0195-6701(95)90328-3

10.1016/0195-6701(91)90223-U

10.2307/30144208

10.1016/0002-9343(78)90777-5

10.1378/chest.120.4.1072

10.1093/clinids/20.4.790

10.1086/314040

10.1067/mic.2002.122648

10.1164/ajrccm/139.4.877

10.1378/chest.115.5.1378

10.1007/BF01690727

10.1001/archinte.162.13.1515

10.3201/eid0805.020014

10.1093/jac/41.5.576

10.1016/S0195-6701(03)00046-X

10.1128/AAC.37.4.750

10.1128/JCM.38.9.3299-3305.2000

10.1093/jac/22.Supplement_A.17

10.3109/10408418609108734

10.1093/jac/38.2.245

10.1046/j.1469-0691.2002.00401.x

10.1128/AAC.47.8.2385-2392.2003

10.1128/JCM.41.8.3542-3547.2003

10.1016/S0891-5520(05)70395-0

10.1128/AAC.41.10.2265

10.1099/0022-1317-50-7-642

10.1128/AAC.47.5.1749-1751.2003

10.1093/jac/43.1.157

10.1016/S0167-7012(03)00090-3

10.1128/AAC.45.2.583-588.2001

10.1099/00222615-46-9-721

10.1111/j.1469-0691.1998.tb00052.x

10.1093/jac/dkf254

10.1093/jac/dkg222

10.1128/AAC.46.6.1946-1952.2002

10.1128/AAC.43.6.1406

10.1093/jac/46.5.827

10.1093/jac/45.4.493

10.1093/jac/47.4.479

10.1086/374337

10.1086/514732

10.1007/s100960000400

10.1007/s10096-001-0680-2

10.1093/infdis/167.2.448

10.1086/340055

10.1016/S0924-8579(02)00276-5

10.1592/phco.21.2.142.34114

10.1093/clinids/24.5.932

10.1592/phco.22.7.527.33676

10.1007/s00134-003-1811-2

10.1016/S0025-7125(16)31447-X

10.1345/aph.18426

2002, Package insert. Coly-Mycin M Parenteral (colistimethate)

10.1378/chest.119.1.250

10.1093/jac/19.6.831

10.1086/517243

10.1111/j.1574-6968.1995.tb07357.x

1997, Package insert. Unasyn (ampicillin sodium—sulbactam sodium)

10.1128/AAC.34.6.958

Thông tin
Thông tin xuất bản

Annals of Pharmacotherapy

Tập 38 Số 9

1449-1459

Thông tin tác giả